Cargando…
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
BACKGROUND: Epithelial cell adhesion molecule is overexpressed in bladder tumours and released from bladder cancer cells in vitro. We test the hypotheses that urinary EpCAM could act as a biomarker for primary bladder cancer detection and risk stratification. METHODS: Epithelial cell adhesion molecu...
Autores principales: | Bryan, R T, Shimwell, N J, Wei, W, Devall, A J, Pirrie, S J, James, N D, Zeegers, M P, Cheng, K K, Martin, A, Ward, D G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915119/ https://www.ncbi.nlm.nih.gov/pubmed/24292452 http://dx.doi.org/10.1038/bjc.2013.744 |
Ejemplares similares
-
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015) -
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013) -
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
por: Snell, Kym I.E., et al.
Publicado: (2018) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2013)